Track topics on Twitter Track topics that are important to you
Cerecor Inc. is acquiring four of Avadel Pharmaceuticals PLC's marketed pediatric products.
BALTIMORE, May 11, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC) (“Cerecor” or the “Company”) today announced financial results for the first quarter of 2018. Net revenues for the fir...
Enter into license agreement to develop four LiquiTime or Micropump products
BALTIMORE, MD--(Marketwired - February 12, 2018) - Cerecor, Inc. (NASDAQ: CERC) today announced it has entered into definitive agreements with Avadel U.S. Holdings, Inc., and certain of its subsidiari...
BALTIMORE, MD--(Marketwired - April 09, 2018) - Cerecor, Inc. (NASDAQ: CERC), today announced that Simon C. Pedder, Ph.D. has been appointed to its Board of Directors. "We are delighted to welcome D...
BALTIMORE, MD--(Marketwired - March 28, 2018) - Cerecor, Inc. (NASDAQ: CERC) today announced that its Board of Directors has appointed Peter Greenleaf as Chief Executive Officer. Mr. Greenleaf has se...
BALTIMORE, MD--(Marketwired - April 02, 2018) - Cerecor Inc. (NASDAQ: CERC) today announced financial results for the fourth quarter and full year 2017. Net Revenues for the year ended 2017 were $27.8...
Driven by an innovative team of industry experts and leading scientists, Cerecor aspires to develop neuroscience drugs that will make a difference. We are committed to improving t...
We have published hundreds of Cerecor Inc. news stories on BioPortfolio along with dozens of Cerecor Inc. Clinical Trials and PubMed Articles about Cerecor Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerecor Inc. Companies in our database. You can also find out about relevant Cerecor Inc. Drugs and Medications on this site too.